Skip to main content
. 2011 Jul;70(7):139–143.

Table 2.

Laboratory data of the 9 previously reported cases and of the authors' patient with renal wasting hypophosphatemia associated with SCC

Patient number Serum phosphorus (mg/dL) (N: 2.5–4.5) TmP/GFR (mg/dL) Serum sodium (mEq/L) Serum cortisol (µg/dL)
Initial After tumor treatment Initial After tumor treatment
2 2.2 3.4 NA 132 141 NA
3 1.9 2.7 NA NA NA NA
4 1.36 1.55 0.8 NA NA NA
4 1.95 3.75 1.1 NA NA NA
5 1.5 NA Very low 113 No 21 (AM)
6 1.2 Still low NA 107- 138 17.3
Authors' Patient 1.2 4.5 0.6 117 127 29.4 (AM)
7 0.84 NA 0.4 117 NA NA
8 0.99 1.08 0.5 143 143 45.38 at 9 am
9 1.2 4.3 -> 1.2–2.8 1.40 107 Corrected and recurrence 35

NA = Not available

HHS Vulnerability Disclosure